meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Cardiovascular Diseases (CVD) & Indoxyl-3-sulfate / Indoxyl sulfate
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Indoxyl-3-sulfate / Indoxyl sulfate is a significant factor in the pathophysiology of cardiovascular diseases, particularly in patients with chronic kidney disease.
Its role in the progression of these diseases and its potential as a predictive marker for Cardiovascular events make it a crucial area of study in the management of cardiovascular diseases in Chronic Renal Failure / Chronic Kidney Disease (CKD) patients.
Both …
References (Sources)
- Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
- Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy
- Indoxyl sulfate: A novel cardiovascular risk factor in chronic kidney disease
- Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease
- Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
- Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts
- Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study